FairValu
STRYKER CORP

STRYKER CORP

SYKNYSE
Medical Devices • Healthcarestryker.com
Current Price
$275.560.00%
Market Cap
$105.70B
Shares Outstanding: 383.57M
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--

Comprehensive AI Analysis

Strategic AI Analysis for SYK

Checking whether the approved providers contain enough current financial data for a reliable report.

Summary

Source-linked company research for SYK

Checking Factor Scorecard coverage

Financial statement coverage is being verified before factor scores are shown.

Price Chart

NYSE:SYK via TradingView

Loading TradingView chart...

Overview

Quarterly income statement data isn't available for this company.

No Data

No annual financial data available.

Financial Fundamentals

Growth, quality, valuation, cash generation, and balance-sheet strength.

Sector: Healthcare

Growth

TTM revenue plus current, long-term, forward, and accelerating top-line trends.

Revenue
-
Revenue Growth
8.5%
Moderate
Revenue CAGR 3Y
-
Forward Revenue Growth
8.6%
Moderate
Revenue Acceleration
-2.9%
Slowing

Earnings

Trailing EPS, current EPS growth, long-term compounding, surprise, and forward expectations.

EPS (TTM)
9.72
Profitable
EPS Growth
27.8%
Strong
EPS CAGR 3Y
-
EPS Surprise
5.8%
Beat
Forward EPS
15.01
Profitable
Fwd Revenue Growth
8.6%
Forward EPS Growth
11.6%
Moderate

Profitability

TTM margin and return metrics that reflect pricing power and business quality.

Gross Margin
65.0%
High
Operating Margin
21.4%
High
Net Margin
14.4%
High
Margin vs Trend
-
ROE
15.5%
Excellent
ROIC
11.3%
Strong

Cash Flow

TTM free cash flow, growth, margin, and operating-cash conversion quality.

Free Cash Flow
$4.70B
Positive
FCF Growth
16.8%
Strong
FCF Margin
-
Cash Conversion
1.48x
Excellent

Valuation

Metrics ranked by issuer type, financial state, and input quality.

Established companyPrimary lens

Forward P/E

Forward P/E is the primary lens because positive expected earnings make the next operating period directly assessable.

Forward P/EPrimary
18.36x
Typical
EV / EBITDASupporting
16.39x
Typical
EV / FCFSupporting
24.94x
Typical
Trailing P/ESupporting
28.34x
High

Financial Health

Latest-quarter liquidity and leverage checks plus TTM interest coverage.

Current Ratio
2.16x
Healthy
Quick Ratio
1.07x
Healthy
Debt / Equity
0.62x
Moderate
Interest Coverage
9.73x
Safe

Shareholder Signals

Capital returns and dilution checks sourced from statements and insider filings.

Dividend Yield
1.2%
Low/None
Payout Ratio
35.3%
Sustainable
Net Insider Buys
-15
Selling

Peer Comparison

TickerPrice
SYKSTRYKER CORP
$275.56
Company Profile

About the Company

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Next Earnings Date

Oct 29, 2026

Loading latest news...

Revenue segmentation

Loading segment disclosures…